Kevin J. Tracey is President and CEO of The Feinstein Institutes for Medical Research; Professor of Neurosurgery and Molecular Medicine at the Zucker School of Medicine at Hofstra-Northwell; and Executive Vice President, Research, at Northwell Health, in New York. A leader in the fields of inflammation research and bioelectronic medicine, his contributions to science include discovery and molecular mapping of neural circuits that control immune responses; identifying HMGB1 as a therapeutic target at the intersection of sterile and infective inflammation; and identifying the therapeutic anti-inflammatory activity of monoclonal anti-TNF antibodies. Professor Tracey received his B.S. (Chemistry, summa cum laude, Phi Beta Kappa) from Boston College in 1979, and his M.D. from Boston University in 1983. He trained in neurosurgery from 1983 to 1992 at the New York Hospital-Cornell University Medical, Center, and was a guest investigator at the Rockefeller University, before moving in 1992 to The Feinstein Institutes in New York.
An inventor with more than 60 United States patents, and author of more than 360 scientific publications, he is also cofounder of the Global Sepsis Alliance, a non-profit organization supporting the efforts of >1 million caregivers in more than 70 countries. His honors and awards include a Doctorate honoris causa from the Karolinska Institute, Stockholm, Sweden and lectureships from Harvard, Yale, Rockefeller University, the NIH, and elsewhere. He has been elected or inducted into the American Society of Clinical Investigation (2001), the American Association of Physicians (2009), the Long Island Technology Hall of Fame (2012), Alpha Omega Alpha (2014), and is a Fellow in the American Association for the Advancement of Science.